Knowledge indicating greater safety from first dose than beforehand thought highlighted
Giving consideration to longer intervals between the primary and second doses of the Pfizer-BioNTech vaccine is being urged by Dr Elizabeth Brint, an immunologist at College Faculty Cork’s Division of Pathology.
The most recent knowledge on the affect of the primary dose of the Pfizer-BioNtech vaccine ought to give trigger for a rethink of Eire’s Covid-19 immunisation technique, based on Dr Brint.
She believes it may very well be time to think about spreading out the time between administering the primary and second dose of the vaccine, thus permitting extra individuals to obtain their first shot sooner.
“Covid transmission charges stay stubbornly excessive. Public compliance with restrictions appears, anecdotally, to be on the wane. We’re a much-needed return to high school and childcare for kids. The so-called Brazilian variant has now been detected in our inhabitants as of final week, and expertise tells us that this can unfold regardless of containment efforts. All these elements predict a possible enhance in unfold over the following few weeks,” she mentioned in a press release issued at this time.
“Nevertheless latest knowledge revealed within the medical journal The Lancet on Friday, signifies that the primary dose of the Pfizer-BioNtech vaccine confers a lot greater safety than beforehand thought.
“As well as, rising proof reveals that vaccination is certainly decreasing transmission. Subsequently, certainly it’s time for a vaccination technique rethink with a shift to a mannequin extra like what the UK is perusing, which is presently attaining good outcomes, with extra individuals receiving the primary dose and spacing the second dose out extra to, for instance, 9 to 12 weeks.
“Immunology tells us that this can work and there’s no cause to imagine any drop in general safety if we house the doses between first and second dose,” she added.